Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Discovery and development of Orally available JNK3 inhibitors as therapeutics for Alzheimer's Disease
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 하정미 | - |
| dc.date.accessioned | 2022-12-20T06:13:11Z | - |
| dc.date.available | 2022-12-20T06:13:11Z | - |
| dc.date.issued | 2023-09-04 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/172981 | - |
| dc.title | Discovery and development of Orally available JNK3 inhibitors as therapeutics for Alzheimer's Disease | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | EUROPEAN Federation OF MEDICINAL CHEMISTRY 2023 | - |
| dc.citation.conferencePlace | 지그레브, 크로아티아 | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 성형외과학교실 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Hah, Jung Mi
- COLLEGE OF PHARMACY (DEPARTMENT OF PHARMACY)